We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.26%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$2.27B
AUM Growth
+$198M
(+9.6%)
Cap. Flow
+$119M
Cap. Flow
% of AUM
5.25%
Top 10 Holdings %
Top 10 Hldgs %
35.16%
Holding
449
New
157
Increased
70
Reduced
62
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$84.2M |
| 2 |
Charter Communications
CHTR
|
+$83.5M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$56.6M |
| 4 |
Bank of America
BAC
|
+$43.5M |
| 5 |
Lowe's Companies
LOW
|
+$38.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$170M |
| 2 |
T-Mobile US
TMUS
|
+$71.2M |
| 3 |
Advance Auto Parts
AAP
|
+$34.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$27.2M |
| 5 |
VAL
Valspar
VAL
|
+$22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 15.94% |
| 2 | Healthcare | 14.24% |
| 3 | Communication Services | 13.98% |
| 4 | Consumer Discretionary | 11.95% |
| 5 | Technology | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Danaher
DHR
$135B
| $1.24M | 0.05% |
16,681
-5,627
| -25% | -$421K |
|
177
BioMarin Pharmaceuticals
BMRN
$11.5B
| $1.24M | 0.05% |
13,606
-3,897
| -22% | -$355K |
|
178
Commault Systems
CVLT
$5.89B
| $1.24M | 0.05% |
+22,065
| New | +$1.21M |
|
179
Agilent Technologies
A
$39.1B
| $1.23M | 0.05% |
+20,901
| New | +$1.19M |
|
180
Fortive
FTV
$19B
| $1.23M | 0.05% |
30,946
-16,286
| -34% | -$641K |
|
181
Abbott
ABT
$180B
| $1.22M | 0.05% |
24,951
-13,387
| -35% | -$606K |
|
182
Johnson & Johnson
JNJ
$635B
| $1.19M | 0.05% |
+9,016
| New | +$1.15M |
|
183
Marathon Petroleum
MPC
$90.3B
| $1.19M | 0.05% |
+22,816
| New | +$1.18M |
|
184
Verizon
VZ
$194B
| $1.18M | 0.05% |
+26,307
| New | +$1.23M |
|
185
Atmos Energy
ATO
$29.9B
| $1.18M | 0.05% |
+14,202
| New | +$1.17M |
|
186
PTC
PTC
$13.7B
| $1.17M | 0.05% |
21,303
+2,425
| +13% | +$134K |
|
187
Carlisle Companies
CSL
$13.6B
| $1.16M | 0.05% |
12,232
-11,022
| -47% | -$1.11M |
|
188
Sensient Technologies
SXT
$5.4B
| $1.16M | 0.05% |
+14,336
| New | +$1.16M |
|
189
Cummins
CMI
$91.7B
| $1.15M | 0.05% |
7,110
-5,511
| -44% | -$855K |
|
190
Cintas
CTAS
$82.4B
| $1.15M | 0.05% |
36,348
-39,868
| -52% | -$1.24M |
|
|
THS
191
DELISTED
Treehouse Foods
THS
| $1.13M | 0.05% |
13,811
+4,064
| +42% | +$332K |
|
192
Illumina
ILMN
$29.4B
| $1.1M | 0.05% |
+6,482
| New | +$1.12M |
|
|
JUNO
193
DELISTED
Juno Therapeutics, Inc.
JUNO
| $1.07M | 0.05% |
+35,687
| New | +$881K |
|
194
Trip.com Group
TCOM
$27.5B
| $1.02M | 0.04% |
+18,838
| New | +$999K |
|
195
Consolidated Edison
ED
$41.6B
| $975K | 0.04% |
+12,034
| New | +$973K |
|
196
Weibo
WB
$1.9B
| $964K | 0.04% |
+14,603
| New | +$948K |
|
197
Howmet Aerospace
HWM
$116B
| $951K | 0.04% |
+53,931
| New | +$1.1M |
|
|
PRTK
198
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $942K | 0.04% |
+39,238
| New | +$867K |
|
199
TD Synnex
SNX
$19.4B
| $938K | 0.04% |
+15,636
| New | +$875K |
|
|
GIMO
200
DELISTED
Gigamon Inc.
GIMO
| $920K | 0.04% |
+23,593
| New | +$889K |
|
Similar funds
Marshall Wace's Q2 2017 Portfolio in Review
As of Q2 2017, Marshall Wace held 449 positions worth $2.27B, up 9.6% from $2.07B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $119M of net new capital in Q2 2017, opening 157 new positions and adding to 70 existing holdings. Its largest new stake was State Street Health Care Select Sector SPDR ETF: 742,458 shares worth $58.7M.
By sector, the portfolio is most concentrated in Consumer Staples at 16% of assets, up from 11% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Zoetis, an estimated $170M trimmed.
- Marshall Wace's largest Q2 2017 buy was State Street Health Care Select Sector SPDR ETF: 742,458 shares worth $58.7M.
- Marshall Wace added most to Reynolds American Inc in Q2 2017, an estimated $84.2M increase.
- Marshall Wace's biggest Q2 2017 reduction was Zoetis, cutting an estimated $170M.
- Marshall Wace fully exited Advance Auto Parts in Q2 2017, selling an estimated $34.1M.
- Marshall Wace's ten largest holdings make up 35% of its $2.27B portfolio in Q2 2017.
- Marshall Wace opened 157 new positions and closed 148 in Q2 2017.
- Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $2.27B.
Based on Marshall Wace's 13F filing for Q2 2017, filed 4 Aug 2017.